Labcorp Q3 FY25: where the revenue came from and where it went
The whole income statement of Labcorp for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jul 1 – Sep 30, 2025
- Reported
- Oct 31, 2025
Revenue$3.56B
+9% year over year
Gross profit$1.03B
29% margin
Operating profit$0.40B
11% margin
Net profit$0.26B
7% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 3.56 | 100% | +9% |
| Diagnostics | 2.77 | 78% | +8% |
| Biopharma laboratory | 0.80 | 22% | |
| Cost of revenue | −2.54 | 71% | |
| Gross profit | 1.03 | 29% margin | +1pp |
| SG&A | −0.55 | 16% | −2pp |
| Other | −0.08 | 2% | +0pp |
| Operating profit | 0.40 | 11% margin | +3pp |
| Interest & other costs | −0.06 | ||
| Tax | −0.08 | ||
| Net profit | 0.26 | 7% margin | +2pp |
122 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest